GajdosZKHirschhornJNPalmertMR. What controls the timing of puberty? An update on progress from genetic investigation. Curr Opin Endocrinol Diabetes Obes2009;16:16–24.
2.
Yang-FengTLSeeburgPHFranckeU. Human luteinizing hormone-releasing hormone gene (LHRH) is located on short arm of chromosome 8 (region 8p11.2–p21). Somat Cell Mol Genet1986;12:95–100.
3.
AdelmanJPMasonAJHayflickJSSeeburgPH. Isolation of the gene and hypothalamic cDNA for the common precursor of gonadotropin-releasing hormone and prolactin release-inhibiting factor in human and rat. Proc Natl Acad Sci USA1986;83: 179–183.
4.
LaymanLC. Mutations in human gonadotropin genes and their physiologic significance in puberty and reproduction. Fertil Steril1999;71:201–218.
5.
OjedaSRLomnicziAMastronardiC. Minireview: The neuroendocrine regulation of puberty: Is the time ripe for a systems biology approach?Endocrinology2006;147:1166–1174.
6.
RoseweirAKMillarRP. The role of kisspeptin in the control of gonadotrophin secretion. Hum Reprod Update2009;15:203–212.
7.
RugarliEI. Kallmann syndrome and the link between olfactory and reproductive development. Am J Hum Genet1999;65: 943–948.
8.
Schwanzel-FukudaMBickDPfaffDW. Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Brain Res Mol Brain Res1989;6:311–326.
9.
YoshidaKRutishauserUCrandallJESchwartingGA. Polysialic acid facilitates migration of luteinizing hormone-releasing hormone neurons on vomeronasal axons. J Neurosci1999;19: 794–801.
10.
TussetCTrarbachEBSilveiraLFBeneduzziDMontenegroLLatronicoAC. [Clinical and molecular aspects of congenital isolated hypogonadotropic hypogonadism]. Arq Bras Endocrinol Metabol2011;55:501–511.
11.
AchermannJCWeissJLeeEJJamesonJL. Inherited disorders of the gonadotropin hormones. Mol Cell Endocrinol2001;179:89–96.
12.
BanerjeeIClaytonP. The genetic basis for the timing of human puberty. J Neuroendocrinol2007;19:831–838.
13.
HuhtaniemiIT. The role of mutations affecting gonadotrophin secretion and action in disorders of pubertal development. Best Pract Res Clin Endocrinol Metab2002;16:123–138.
14.
WaldhauserFWeissenbacherGFrischHPollakA. Pulsatile secretion of gonadotropins in early infancy. Eur J Pediatr1981; 137:71–74.
15.
NachtigallLBBoepplePAPralongFPCrowleyWFJr. Adult-onset idiopathic hypogonadotropic hypogonadism–a treatable form of male infertility. N Engl J Med1997;336:410–415.
16.
BurgeMRLanziRASkardaSTEatonRP. Idiopathic hypogonadotropic hypogonadism in a male runner is reversed by clomiphene citrate. Fertil Steril1997;67:783–785.
17.
BoyarRFinkelsteinJRoffwargHKapenSWeitzmanEHellmanL. Synchronization of augmented luteinizing hormone secretion with sleep during puberty. N Engl J Med1972;287:582–586.
18.
LeePAHoukCP. Puberty and its disorders. In: LifshitzF, ed. Pediatric Endocrinology, 5th ed.New York: Informa Healthcare; 2007:273–304.
19.
StyneDM. Puberty and its disorders in boys. Endocrinol Metab Clin North Am1991;20:43–69.
20.
TraggiaiCStanhopeR. Delayed puberty. Best Pract Res Clin Endocrinol Metab2002;16:139–151.
21.
SedlmeyerILPalmertMR. Delayed puberty: Analysis of a large case series from an academic center. J Clin Endocrinol Metab2002;87:1613–1620.
22.
SeminaraSBHayesFJCrowleyWFJr. Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): Pathophysiological and genetic considerations. Endocr Rev1998;19:521–539.
23.
BanerjeeIHansonDPerveenRWhatmoreABlackGCClaytonPE. Constitutional delay of growth and puberty is not commonly associated with mutations in the acid labile subunit gene. Eur J Endocrinol2008;158:473–477.
24.
VaaralahtiKWehkalampiKTommiskaJLaitinenEMDunkelLRaivioT. The role of gene defects underlying isolated hypogonadotropic hypogonadism in patients with constitutional delay of growth and puberty. Fertil Steril2011;95:2756–2758.
25.
El-EshmawyMMAalAbdel IAEl HawaryAK. Association of ghrelin and leptin with reproductive hormones in constitutional delay of growth and puberty. Reprod Biol Endocrinol2010;8:153.
26.
Tena-SempereM. Ghrelin: Novel regulator of gonadal function. J Endocrinol Invest2005;28:26–29.
27.
MunzbergHBjornholmMBatesSHMyersMGJr. Leptin receptor action and mechanisms of leptin resistance. Cell Mol Life Sci2005;62:642–652.
28.
YooHJChoiKMRyuOH. Delayed puberty due to pituitary stalk dysgenesis and ectopic neurohypophysis. Korean J Intern Med2006;21:68–72.
29.
KauschanskyADickermanZPhillipMWeintrobNStrichD. Use of GnRH agonist and human chorionic gonadotrophin tests for differentiating constitutional delayed puberty from gonadotrophin deficiency in boys. Clin Endocrinol (Oxf)2002;56:603–607.
30.
SegalTYMehtaAAnazodoAHindmarshPCDattaniMT. Role of gonadotropin-releasing hormone and human chorionic gonadotropin stimulation tests in differentiating patients with hypogonadotropic hypogonadism from those with constitutional delay of growth and puberty. J Clin Endocrinol Metab2009;94:780–785.
31.
AdanLLechevalierPCouto-SilvaAC. Plasma inhibin B and antimullerian hormone concentrations in boys: Discriminating between congenital hypogonadotropic hypogonadism and constitutional pubertal delay. Med Sci Monit2010;16:CR511–CR517.
32.
PozoJArgenteJ. Delayed puberty in chronic illness. Best Pract Res Clin Endocrinol Metab2002;16:73–90.
33.
AmblerGR. Androgen therapy for delayed male puberty. Curr Opin Endocrinol Diabetes Obes2009;16:232–239.
34.
SolimanATDe SanctisV. An approach to constitutional delay of growth and puberty. Indian J Endocrinol Metab2012;16:698–705.
35.
MacCollGBoulouxPQuintonR. Kallmann syndrome: Adhesion, afferents, and anosmia. Neuron2002;34:675–678.
36.
BeranovaMOliveiraLMBedecarratsGY. Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab2001;86:1580–1588.
37.
BeateKJosephNde NicolasRWolframK. Genetics of isolated hypogonadotropic hypogonadism: Role of GnRH receptor and other genes. Int J Endocrinol2012;2012:147893.
38.
KimHGAhnJWKurthI. WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet2010;87:465–479.
39.
NimriRLebenthalYLazarL. A novel loss-of-function mutation in GPR54/KISS1R leads to hypogonadotropic hypogonadism in a highly consanguineous family. J Clin Endocrinol Metab2011;96:E536–E545.
40.
TopalogluAKReimannFGucluM. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. Nat Genet2009;41:354–358.
41.
TornbergJSykiotisGPKeefeK. Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism. Proc Natl Acad Sci USA2011;108: 11524–11529.
42.
XuNKimHGBhagavathB. Nasal embryonic LHRH factor (NELF) mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome. Fertil Steril2011;95: 1613–1620.e1–7.
43.
YoungJBouligandJFrancouB. TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans. J Clin Endocrinol Metab2010;95:2287–2295.
44.
LaymanLC. Hypogonadotropic hypogonadism. Endocrinol Metab Clin North Am2007;36:283–296.
45.
Pedersen-WhiteJRChorichLPBickDPSherinsRJLaymanLC. The prevalence of intragenic deletions in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Mol Hum Reprod2008;14:367–370.
46.
SeminaraSBOliveiraLMBeranovaMHayesFJCrowleyWFJr. Genetics of hypogonadotropic hypogonadism. J Endocrinol Invest2000;23:560–565.
47.
PallardoLFSantiagoMCerdanANistalM. Algunos aspectos del eunocoidismo hipogonadotropico. Med Clin1972:390–396.
48.
de RouxNYoungJMisrahiMSchaisonGMilgromE. Loss of function mutations of the GnRH receptor: A new cause of hypogonadotropic hypogonadism. J Pediatr Endocrinol Metab1999;12(suppl 1):267–275.
49.
GurbuzFKotanLDMengenE. Distribution of gene mutations associated with familial normosmic idiopathic hypogonadotropic hypogonadism. J Clin Res Pediatr Endocrinol2012;4: 121–126.
50.
PitteloudNQuintonRPearceS. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest2007;117:457–463.
51.
PralongFPGomezFCastilloE. Complete hypogonadotropic hypogonadism associated with a novel inactivating mutation of the gonadotropin-releasing hormone receptor. J Clin Endocrinol Metab1999;84:3811–3816.
52.
RaivioTSidisYPlummerL. Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab2009; 94:4380–4390.
53.
TrarbachEBCostaEMVersianiB. Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia. J Clin Endocrinol Metab2006;91:4006–4012.
54.
YoungJReyRCouzinetBChansonPJossoNSchaisonG. Antimullerian hormone in patients with hypogonadotropic hypogonadism. J Clin Endocrinol Metab1999;84:2696–2699.
55.
de KretserDM. The fine structure of the immature human testis in hypogonadotrophic hypogonadism. Virchows Arch B Cell Pathol1968;1:283–296.
PitteloudNHayesFJDwyerABoepplePALeeHCrowleyWFJr. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab2002;87:4128–4136.
58.
NistalMPaniaguaRGonzález-PeramatoReyes-MúgicaM. Perspectives in pediatric pathology, chapter 14. Natural history of undescended testes. Pediatr Dev Pathol2016;19:183–201.
59.
De San JuanMaestre A. Teratologia: Falta total de nervios olfatorios con anosmia en un individuo en quien existia una atrofia congenita de los testiculos y miembro. El Siglo Medico1856:211–221.
60.
KallmannFJSchoenfeldWABarreraSE. The genetic aspects of primary eunuchoidism. Am J Ment Defic1944:203–236.
61.
De MorsierG. Etudes sur les dysraphies cranio-encephaliques. 1. Agenesie des lobes olfactifs (telecephaloschizis lateral) et des comissures calleuse et anterieure (telencephaloschizis median) La dysplasie olfacto-genitale. Schweiz Arch Neurol Neurochir Psychiatr1954:309–313.
62.
QuintonRDukeVMde ZoysaPA. The neuroradiology of Kallmann's syndrome: A genotypic and phenotypic analysis. J Clin Endocrinol Metab1996;81:3010–3017.
63.
WustenbergEGFleischerAGerbertBAbolmaaliNHuttenbrinkKBHummelT. [Normal sense of smell in Kallmann syndrome. A case report]. Laryngorhinootologie2001;80:85–89.
64.
PawlowitzkiIHDiekstallPSchadelAMinyP. Estimating frequency of Kallmann syndrome among hypogonadic and among anosmic patients. Am J Med Genet1987;26:473–479.
65.
BickDFrancoBSherinsRJ. Brief report: Intragenic deletion of the KALIG-1 gene in Kallmann's syndrome. N Engl J Med1992;326:1752–1755.
66.
GeorgopoulosNAPralongFPSeidmanCESeidmanJGCrowleyWFJrVallejoM. Genetic heterogeneity evidenced by low incidence of KAL-1 gene mutations in sporadic cases of gonadotropin-releasing hormone deficiency. J Clin Endocrinol Metab1997;82:213–217.
67.
Maya-NunezGCuevas-CovarrubiasSZentenoJCUlloa-AguirreAKofman-AlfaroSMendezJP. Contiguous gene syndrome due to deletion of the first three exons of the Kallmann gene and complete deletion of the steroid sulphatase gene. Clin Endocrinol (Oxf)1998;48:713–718.
68.
SantenRJPaulsenCA. Hypogonadotropic eunuchoidism. I. Clinical study of the mode of inheritance. J Clin Endocrinol Metab1973;36:47–54.
MeitingerTHeyeBPetitC. Definitive localization of X-linked Kallman syndrome (hypogonadotropic hypogonadism and anosmia) to Xp22.3: Close linkage to the hypervariable repeat sequence CRI-S232. Am J Hum Genet1990;47:664–669.
71.
LegouisRHardelinJPLevilliersJ. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell1991;67:423–435.
72.
BulowHEBerryKLTopperLHPelesEHobertO. Heparan sulfate proteoglycan-dependent induction of axon branching and axon misrouting by the Kallmann syndrome gene kal-1. Proc Natl Acad Sci USA2002;99:6346–6351.
73.
PitteloudNMeysingAQuintonR. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes. Mol Cell Endocrinol2006; 254–255:60–69.
74.
TsaiPSGillJC. Mechanisms of disease: Insights into X-linked and autosomal-dominant Kallmann syndrome. Nat Clin Pract Endocrinol Metab2006;2:160–171.
75.
MombaertsPWangFDulacC. Visualizing an olfactory sensory map. Cell1996;87:675–686.
76.
RugarliEIGhezziCValsecchiVBallabioA. The Kallmann syndrome gene product expressed in COS cells is cleaved on the cell surface to yield a diffusible component. Hum Mol Genet1996;5:1109–1115.
77.
TeixeiraLGuimiotFDodeC. Defective migration of neuroendocrine GnRH cells in human arrhinencephalic conditions. J Clin Invest2010;120:3668–3672.
78.
BickDPBallabioA. Bringing Kallmann syndrome into focus. AJNR Am J Neuroradiol1993;14:852–854.
79.
DanekAHeyeBSchroedterR. Cortically evoked motor responses in patients with Xp22.3-linked Kallmann's syndrome and in female gene carriers. Ann Neurol1992;31:299–304.
80.
KaplanJDBernsteinJAKwanAHudginsL. Clues to an early diagnosis of Kallmann syndrome. Am J Med Genet A2010;152A: 2796–2801.
81.
ChristensenRBMatsumotoAMBremnerWJ. Idiopathic hypogonadotropic hypogonadism with anosmia (Kallmann's syndrome). Endocrinologist1992:332–340.
82.
PervaizNHagedoornJMininbergDT. Electron microscopic studies of testes in Kallman syndrome. Urology1979;14:267–269.
83.
EnriquezLGarciaDiaz-Rubio MZamarronAParamoGonzalez PNistalM. [Hypogonadotropic hypogonadism with anosmia]. Rev Clin Esp1973;131:383–392.
84.
Bailleul-ForestierIGrosCZenatyDBennaceurSLegerJde RouxN. Dental agenesis in Kallmann syndrome individuals with FGFR1 mutations. Int J Paediatr Dent2010;20:305–312.
85.
SchwankhausJDCurrieJJaffeMJRoseSRSherinsRJ. Neurologic findings in men with isolated hypogonadotropic hypogonadism. Neurology1989;39:223–226.
86.
WaldstreicherJSeminaraSBJamesonJL. The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human. J Clin Endocrinol Metab1996;81:4388–4395.
87.
KirkJMGrantDBBesserGM. Unilateral renal aplasia in X-linked Kallmann's syndrome. Clin Genet1994;46:260–262.
88.
AlbersDDMalesJL. Seminoma in hypogonadotropic hypogonadism associated with anosmia (Kallmann's syndrome). J Urol1981; 126:57–58.
89.
BallabioAAndriaG. Deletions and translocations involving the distal short arm of the human X chromosome: Review and hypotheses. Hum Mol Genet1992;1:221–227.
90.
BallabioABardoniBCarrozzoR. Contiguous gene syndromes due to deletions in the distal short arm of the human X chromosome. Proc Natl Acad Sci USA1989;86:10001–10005.
91.
Maya-NunezGZentenoJCUlloa-AguirreAKofman-AlfaroSMendezJP. A recurrent missense mutation in the KAL gene in patients with X-linked Kallmann's syndrome. J Clin Endocrinol Metab1998;83:1650–1653.
92.
ZhangSWangTYangJLiuZWangSLiuJ. A fertile male patient with Kallmann syndrome and two missense mutations in the KAL1 gene. Fertil Steril2011;95:1789.e3–e6.
93.
PasqualiniRQBurG. Hypoandrogenic syndrome with spermatogenesis. Fertil Steril1955;6:144–157.
94.
PasqualiniRQBurGE. Síndrome hipoandrogénico con gameto-génesis conservada: Clasificación de la insuficiencia testicular. Rev Asoc Med Argent1950:64:15–30.
95.
McCullaghEPBeckJCSchaffenburgCA. A syndrome of eunuchoidism with spermatogenesis, normal urinary FSH and low or normal ICSH: (fertile eunuchs). J Clin Endocrinol Metab1953; 13:489–509.
96.
FaimanCHoffmanDLRyanRJAlbertA. The “fertile eunuch” syndrome: Demonstration of isolated luteinizing hormone deficiency by radioimmunoassay technique. Mayo Clin Proc1968; 43:661–667.
97.
del PozoEBolteEVeryM. Suprasellar disturbance in the syndrome of fertile eunuchoidism: Case report. Acta Endocrinol (Copenh)1975;80:165–170.
98.
SchroffnerWGFurthED. Hypogonadotropic hypogonadism with anosmia (Kallmann's syndrome) unresponsive to clomiphene citrate. J Clin Endocrinol Metab1970;31:267–270.
99.
ArnholdIJLofrano-PortoALatronicoAC. Inactivating mutations of luteinizing hormone beta-subunit or luteinizing hormone receptor cause oligo-amenorrhea and infertility in women. Horm Res2009;71:75–82.
100.
ShiraishiKNaitoK. Fertile eunuch syndrome with the mutations (Trp8Arg and Ile15Thr) in the beta subunit of luteinizing hormone. Endocr J2003;50:733–737.
101.
PitteloudNBoepplePADeCruzSValkenburghSBCrowleyWFJrHayesFJ. The fertile eunuch variant of idiopathic hypogonadotropic hypogonadism: Spontaneous reversal associated with a homozygous mutation in the gonadotropin-releasing hormone receptor. J Clin Endocrinol Metab2001;86:2470–2475.
102.
HashimotoTMiyaiKIzumiKKumaharaY. Isolated gonadotropin deficiency with response to luteinizing-hormone-releasing hormone. N Engl J Med1972;287:1059–1062.
103.
SprattDICarrDBMerriamGRScullyRERaoPNCrowleyWFJr. The spectrum of abnormal patterns of gonadotropin-releasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism: Clinical and laboratory correlations. J Clin Endocrinol Metab1987;64:283–291.
104.
MaklerAGlezermanMLunenfeldB. The fertile eunuch syndrome. An isolated leydig-cell failure?Andrologia1977;9: 163–170.
105.
ZacharinMSabinMANairVVDabadghaoP. Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis. Fertil Steril2012;98:836–842.
106.
LaitinenEMTommiskaJSaneTVaaralahtiKToppariJRaivioT. Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations. PLoS One2012;7:e39450.
107.
LaymanLC. Mutations in the follicle-stimulating hormone-beta (FSH beta) and FSH receptor genes in mice and humans. Semin Reprod Med2000;18:5–10.
108.
LaymanLCPortoALXieJ. FSH beta gene mutations in a female with partial breast development and a male sibling with normal puberty and azoospermia. J Clin Endocrinol Metab2002; 87:3702–3707.
109.
BergerKSouzaHBritoVNd'AlvaCBMendoncaBBLatronicoAC. Clinical and hormonal features of selective follicle-stimulating hormone (FSH) deficiency due to FSH beta-subunit gene mutations in both sexes. Fertil Steril2005;83:466–470.
110.
ClarkADLaymanLC. Analysis of the Cys82Arg mutation in follicle-stimulating hormone beta (FSHbeta) using a novel FSH expression vector. Fertil Steril2003;79:379–385.
111.
LamminenTJokinenPJiangMPakarinenPSimonsenHHuhtaniemiI. Human FSH beta subunit gene is highly conserved. Mol Hum Reprod2005;11:601–605.
112.
Lofrano-PortoACasulariLANascimentoPP. Effects of follicle-stimulating hormone and human chorionic gonadotropin on gonadal steroidogenesis in two siblings with a follicle-stimulating hormone beta subunit mutation. Fertil Steril2008;90:1169–1174.
113.
DiezJJIglesiasPSastreJ. Isolated deficiency of follicle-stimulating hormone in man: A case report and literature review. Int J Fertil Menopausal Stud1994;39:26–31.
114.
LindstedtGNystromEMatthewsCErnestIJansonPOChatterjeeK. Follitropin (FSH) deficiency in an infertile male due to FSHbeta gene mutation. A syndrome of normal puberty and virilization but underdeveloped testicles with azoospermia, low FSH but high lutropin and normal serum testosterone concentrations. Clin Chem Lab Med1998;36:663–665.
GiltayJCDeegeMBlankensteinRAKastropPMWijmengaCLockTT. Apparent primary follicle-stimulating hormone deficiency is a rare cause of treatable male infertility. Fertil Steril2004;81:693–696.
117.
AxelrodLNeerRMKlimanB. Hypogonadism in a male with immunologically active, biologically inactive luteinizing hormone: An exception to a venerable rule. J Clin Endocrinol Metab1979;48: 279–287.
118.
BeitinsIZAxelrodLOstreaTLittleRBadgerTM. Hypogonadism in a male with an immunologically active, biologically inactive luteinizing hormone: Characterization of the abnormal hormone. J Clin Endocrinol Metab1981;52:1143–1149.
119.
WeissJAxelrodLWhitcombRWHarrisPECrowleyWFJamesonJL. Hypogonadism caused by a single amino acid substitution in the beta subunit of luteinizing hormone. N Engl J Med1992;326:179–183.
120.
WangCDahlKDLeungAChanSYHsuehAJ. Serum bioactive follicle-stimulating hormone in men with idiopathic azoospermia and oligospermia. J Clin Endocrinol Metab1987;65:629–633.
121.
Beck-PeccozPRomoliRPersaniL. Mutations of LH and FSH receptors. J Endocrinol Invest2000;23:566–572.
122.
SalviRPralongFP. Molecular characterization and phenotypic expression of mutations in genes for gonadotropins and their receptors in humans. Front Horm Res2010;39:1–12.
123.
ThemmenAPNHuhtaniemiIT. Mutations of gonadotropins and gonadotropin receptors: Elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev2000;21:551–83.
124.
EuniceMPhilibertPKulshreshthaB. Mother-to-son transmission of a luteinizing hormone receptor activating mutation in a prepubertal child with testotoxicosis. J Pediatr Endocrinol Metab2009;22:275–279.
125.
ShenkerALaueLKosugiSMerendinoJJJrMinegishiTCutlerGBJr. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature1993;365:652–654.
126.
NistalMPaniaguaRGonzález-PeramatoReyes-MúgicaM. Perspectives in pediatric pathology, chapter 15. Macrorchidism as the expression of several congenital and acquired pathologies. Pediatr Dev Pathol2016;19:202–218.
127.
NistalMPaniaguaRGonzález-PeramatoReyes-MúgicaM. Perspectives in pediatric pathology, chapter 6. Male undermasculinization. Pediatr Dev Pathol2015;18:279–296.
128.
TapanainenJSAittomakiKMinJVaskivuoTHuhtaniemiIT. Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat Genet1997;15:205–206.
129.
GromollJSimoniMNieschlagE. An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. J Clin Endocrinol Metab1996;81:1367–1370.
130.
ShohamZZalelYJacobsHS. The role of growth hormone in male infertility. Clin Endocrinol (Oxf)1994;41:1–5.
131.
LaronZSarelRPertzelanA. Puberty in Laron type dwarfism. Eur J Pediatr1980;134:79–83.
132.
TatoLZamboniGAntoniazziFPiubelloG. Gonadal function and response to growth hormone (GH) in boys with isolated GH deficiency and to GH and gonadotropins in boys with multiple pituitary hormone deficiencies. Fertil Steril1996;65:830–834.
133.
ShimonovitzSZacutDChetritBen ARonM. Growth hormone status in patients with maturation arrest of spermatogenesis. Hum Reprod1993;8:919–921.
134.
MagonNSinghSSaxenaASahayR. Growth hormone in male infertility. Indian J Endocrinol Metab2011;15(suppl 3):S248–S249.
135.
OvesenPJorgensenJOKjaerTHoKKOrskovHChristiansenJS. Impaired growth hormone secretion and increased growth hormone-binding protein levels in subfertile males. Fertil Steril1996;65:165–169.
136.
OvesenPGJorgensenJOIngerslevJOrskovHChristiansenJS. [Growth hormone treatment of men with reduced sperm quality]. Ugeskr Laeger1998;160:176–180.
137.
PraderALabhartAWilliH. Ein syndrom von adipositas, Kleinwuchs, Kryptorchismus, und Oligophrenie nach myotonieatingem Zustand im Neugeborenenalter. Schweiz Med Wochenschr1956:1260–1261.
138.
DieneGMimounEFeigerlovaE. Endocrine disorders in children with Prader-Willi syndrome—data from 142 children of the French database. Horm Res Paediatr2010;74:121–128.
PartschCJLammerCGillessen-KaesbachGPankauR. Adult patients with Prader-Willi syndrome: Clinical characteristics, life circumstances and growth hormone secretion. Growth Horm IGF Res2000;10(suppl B):S81–S85.
141.
McEntagartMEWebbTHardyCKingMD. Familial Prader-Willi syndrome: Case report and a literature review. Clin Genet2000;58:216–223.
142.
SiemensmaEPde Lind van WijngaardenRFOttenBJde JongFHHokken-KoelegaAC. Testicular failure in boys with Prader-Willi syndrome: Longitudinal studies of reproductive hormones. J Clin Endocrinol Metab2012;97:E452–E459.
143.
UehlingD. Cryptorchidism in the Prader-Willi syndrome. J Urol1980;124:103–104.
144.
CrinoASchiaffiniRCiampaliniP. Hypogonadism and pubertal development in Prader-Willi syndrome. Eur J Pediatr2003;162:327–333.
145.
HirschHJEldar-GevaTBenarrochFRubinsteinOGross-TsurV. Primary testicular dysfunction is a major contributor to abnormal pubertal development in males with Prader-Willi syndrome. J Clin Endocrinol Metab2009;94:2262–2268.
146.
KatcherMLBargmanGJGilbertEFOpitzJM. Absence of spermatogonia in the Prader-Willi syndrome. Eur J Pediatr1977; 124:257–260.
VogelsAMoermanPFrijnsJPBogaertGA. Testicular histology in boys with Prader-Willi syndrome: Fertile or infertile?J Urol2008;180:1800–1804.
149.
EiholzerUl'AllemandDRoussonV. Hypothalamic and gonadal components of hypogonadism in boys with Prader-Labhart-Willi syndrome. J Clin Endocrinol Metab2006;91:892–898.
150.
Gross-TsurVHirschHJBenarrochFEldar-GevaT. The FSH-inhibin axis in Prader-Willi syndrome: Heterogeneity of gonadal dysfunction. Reprod Biol Endocrinol2012;10:39.
151.
RadicioniAFDi GiorgioGGrugniG. Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome. Clin Endocrinol (Oxf)2012;76: 72–77.
152.
EmerickJEVogtKS. Endocrine manifestations and management of Prader-Willi syndrome. Int J Pediatr Endocrinol2013; 2013:14.
153.
van NieuwpoortICSinnemaMCastelijnsJATwiskJWCurfsLMDrentML. The GH/IGF-I axis and pituitary function and size in adults with Prader-Willi syndrome. Horm Res Paediatr2011;75: 403–411.
154.
WannarachueNRuvalcabaRH. Hypogonadism in Prader-Willi syndrome. Am J Ment Defic1975;79:592–603.
155.
ButlerMG. Prader-Willi syndrome: Current understanding of cause and diagnosis. Am J Med Genet1990;35:319–332.
156.
ButlerMGPalmerCG. Parental origin of chromosome 15 deletion in Prader-Willi syndrome. Lancet1983;1:1285–1286.
157.
KnollJHWagstaffJLalandeM. Cytogenetic and molecular studies in the Prader-Willi and Angelman syndromes: An overview. Am J Med Genet1993;46:2–6.
158.
LedbetterDHRiccardiVMAirhartSDStrobelRJKeenanBSCrawfordJD. Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. N Engl J Med1981;304:325–329.
159.
MatteiJFMatteiMGGiraudF. Prader-Willi syndrome and chromosome 15. A clinical discussion of 20 cases. Hum Genet1983;64:356–362.
160.
RobinsonWPBottaniAXieYG. Molecular, cytogenetic, and clinical investigations of Prader-Willi syndrome patients. Am J Hum Genet1991;49:1219–1234.
161.
SuzukiYSasagawaIYazawaHTatenoTNakadaT. Detection of chromosome 15 deletion in Prader-Willi syndrome using fluorescence in situ hybridization. Arch Androl2000;45:13–17.
162.
ASHG/ACMG. Diagnostic testing for Prader-Willi and Angelman syndromes: Report of the ASHG/ACMG Test and Technology Transfer Committee. Am J Hum Genet1996;58:1085–1088.
163.
DittrichBBuitingKKornB. Imprint switching on human chromosome 15 may involve alternative transcripts of the SNRPN gene. Nat Genet1996;14:163–70.
164.
ReisADittrichBGregerV. Imprinting mutations suggested by abnormal DNA methylation patterns in familial Angelman and Prader-Willi syndromes. Am J Hum Genet1994;54: 741–747.
165.
SaitohSBuitingKCassidySB. Clinical spectrum and molecular diagnosis of Angelman and Prader-Willi syndrome patients with an imprinting mutation. Am J Med Genet1997;68: 195–206.
SmeetsDFHamelBCNelenMR. Prader-Willi syndrome and Angelman syndrome in cousins from a family with a translocation between chromosomes 6 and 15. N Engl J Med1992;326: 807–811.
169.
NichollsRD. New insights reveal complex mechanisms involved in genomic imprinting. Am J Hum Genet1994;54:733–740.
170.
Toth-FejelSOlsonSGunterK. The impact of imprinting: Prader-Willi syndrome resulting from chromosome translocation, recombination, and nondisjunction. Am J Hum Genet1996;58: 1008–1016.
171.
Gunay-AygunMSchwartzSHeegerSO'RiordanMACassidySB. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics2001; 108:E92.
172.
NativioDG. The genetics, diagnosis, and management of Prader-Willi syndrome. J Pediatr Health Care2002;16:298–303.
173.
BardetG. Sur un syndrome d'obesite congenitale avec polydactylie et retinite pigmentaire (contribution a l'etude des formes cliniques de l'obesite hypophysaire). Paris: Thesis; 1920.
174.
BiedlA. Ein geschwisterpaar mit adiposo-geneitaler dystrophie. DtschMed Wochenschr1922;48:1630.
175.
GreenJSParfreyPSHarnettJD. The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N Engl J Med1989;321:1002–1009.
176.
IannelloSBoscoPCavaleriACamutoMMilazzoPBelfioreF. A review of the literature of Bardet-Biedl disease and report of three cases associated with metabolic syndrome and diagnosed after the age of fifty. Obes Rev2002;3:123–135.
177.
WoodsMOYoungTLParfreyPSHeffertonDGreenJSDavidsonWS. Genetic heterogeneity of Bardet-Biedl syndrome in a distinct Canadian population: Evidence for a fifth locus. Genomics1999;55:2–9.
178.
RooryckCLacombeD. [Bardet-Biedl syndrome]. Ann Endocrinol (Paris)2008;69:463–471.
179.
SolimanATRajabAAlSalmiIAsfourMG. Empty sellae, impaired testosterone secretion, and defective hypothalamic-pituitary growth and gonadal axes in children with Bardet-Biedl syndrome. Metabolism1996;45:1230–1234.
180.
ToledoSPMedeiros-NetoGAKnobelMMattarE. Evaluation of the hypothalamic-pituitary-gonadal function in the Bardet-Biedl syndrome. Metabolism1977;26:1277–1291.
181.
MozaffarianGNakhjavaniMKFarrahiA. The Laurence-Moon-Bardet-Biedl syndrome: Unresponsiveness to the action of testosterone, a possible mechanism. Fertil Steril1979;31:417–422.
182.
DesaiAJhaOIyerVDadaRKumarRTandonN. Reversible hypogonadism in Bardet-Biedl syndrome. Fertil Steril2009;92:391e13–e15.
183.
GhadamiMTomitaHANajafiMT. Bardet-Biedl syndrome type 3 in an Iranian family: Clinical study and confirmation of disease localization. Am J Med Genet2000;94:433–437.
184.
GuranTEkinciGAtayZTuranSAkcayTBereketA. Radiologic and hormonal evaluation of pituitary abnormalities in patients with Bardet-Biedl syndrome. Clin Dysmorphol2011;20: 26–31.
185.
JanssenSRamaswamiGDavisEE. Mutation analysis in Bardet-Biedl syndrome by DNA pooling and massively parallel resequencing in 105 individuals. Hum Genet2011;129:79–90.
186.
KhanSUllahIIrfanullah. Novel homozygous mutations in the genes ARL6 and BBS10 underlying Bardet-Biedl syndrome. Gene2013;515:84–88.
187.
MarionVStutzmannFGerardM. Exome sequencing identifies mutations in LZTFL1, a BBSome and smoothened trafficking regulator, in a family with Bardet-Biedl syndrome with situs inversus and insertional polydactyly. J Med Genet2012;49: 317–321.
188.
MykytynKNishimuraDYSearbyCC. Identification of the gene (BBS1) most commonly involved in Bardet-Biedl syndrome, a complex human obesity syndrome. Nat Genet2002;31:435–438.
189.
LeeJEGleesonJG. Cilia in the nervous system: Linking cilia function and neurodevelopmental disorders. Curr Opin Neurol2011;24:98–105.
190.
BealesPLElciogluNWoolfASParkerDFlinterFA. New criteria for improved diagnosis of Bardet-Biedl syndrome: Results of a population survey. J Med Genet1999;36:437–446.
191.
BealesPLWarnerAMHitmanGAThakkerRFlinterFA. Bardet-Biedl syndrome: A molecular and phenotypic study of 18 families. J Med Genet1997;34:92–98.
192.
BlacqueOELerouxMR. Bardet-Biedl syndrome: An emerging pathomechanism of intracellular transport. Cell Mol Life Sci2006; 63:2145–2161.
193.
BrufordEARiiseRTeaguePW. Linkage mapping in 29 Bardet-Biedl syndrome families confirms loci in chromosomal regions 11q13, 15q22.3-q23, and 16q21. Genomics1997;41:93–99.
194.
Cardenas-RodriguezMOsbornDPIrigoinF. Characterization of CCDC28B reveals its role in ciliogenesis and provides insight to understand its modifier effect on Bardet-Biedl syndrome. Hum Genet2013;132:91–105.
195.
CarmiRRokhlinaTKwitek-BlackAE. Use of a DNA pooling strategy to identify a human obesity syndrome locus on chromosome 15. Hum Mol Genet1995;4:9–13.
196.
Kwitek-BlackAECarmiRDuykGM. Linkage of Bardet-Biedl syndrome to chromosome 16q and evidence for non-allelic genetic heterogeneity. Nat Genet1993;5:392–396.
197.
LeitchCCZaghloulNADavisEE. Hypomorphic mutations in syndromic encephalocele genes are associated with Bardet-Biedl syndrome. Nat Genet2008;40:443–448.
198.
LeppertMBairdLAndersonKLOtterudBLupskiJRLewisRA. Bardet-Biedl syndrome is linked to DNA markers on chromosome 11q and is genetically heterogeneous. Nat Genet1994;7:108–112.
199.
SheffieldVCCarmiRKwitek-BlackA. Identification of a Bardet-Biedl syndrome locus on chromosome 3 and evaluation of an efficient approach to homozygosity mapping. Hum Mol Genet1994;3:1331–1335.
200.
YoungTLPenneyLWoodsMO. A fifth locus for Bardet-Biedl syndrome maps to chromosome 2q31. Am J Hum Genet1999;64:900–904.
201.
RudE. Et tifaelde of infantilisme wied tetani, epilepsi, polyneuritis, ichthyosis og anaemi of pernicios type. Hospitalstidende1927;70:525–538.
202.
StollCEyerD. A syndrome of congenital ichthyosis, hypogonadism, small stature, facial dysmorphism, scoliosis and myogenic dystrophy. Ann Genet1999;42:45–50.
Dacou–VoutetakisCDrakopoulouM. Ichthyosis and hypogonadism in two brothers with deletion of the short arm of the X chromosome. Horm Res1988;30:173–176; discussion 177.
205.
Maya-NunezGTorresLUlloa-AguirreA. An atypical contiguous gene syndrome: Molecular studies in a family with X-linked Kallmann's syndrome and X-linked ichthyosis. Clin Endocrinol (Oxf)1999;50:157–162.
206.
PaigeDGEmilionGGBoulouxPMHarperJI. A clinical and genetic study of X-linked recessive ichthyosis and contiguous gene defects. Br J Dermatol1994;131:622–629.
207.
CushmanLJTorres-MartinezWWeaverDD. Johnson-McMillin syndrome: Report of a new case with novel features. Birth Defects Res A Clin Mol Teratol2005;73:638–641.
208.
JohnsonVPMcMillinJMAcetoTJrBruinsG. A newly recognized neuroectodermal syndrome of familial alopecia, anosmia, deafness, and hypogonadism. Am J Med Genet1983; 15:497–506.
209.
JohnstonKGolabiMHallBItoMGrixA. Alopecia-anosmia-deafness-hypogonadism syndrome revisited: Report of a new case. Am J Med Genet1987;26:925–927.
210.
NeuhauserGOpitzJM. Autosomal recessive syndrome of cerebellar ataxia and hypogonadotropic hypogonadism. Clin Genet1975;7:426–434.
211.
OharaSKondoKMaruyamaKYanagisawaN. [Cerebellar ataxia with hypogonadotropic hypogonadism]. Rinsho Shinkeigaku1992;32:209–212.
212.
RushtonARGenelM. Hereditary ectodermal dysplasia, olivo-pontocerebellar degeneration, short stature, and hypogonadism. J Med Genet1981;18:335–339.
213.
BercianoJAmadoJAFreijanesJRebolloMVaqueroA. Familial cerebellar ataxia and hypogonadotropic hypogonadism: Evidence for hypothalamic LHRH deficiency. J Neurol Neurosurg Psychiatry1982;45:747–751.
214.
TojoKIchinoseMNakayamaM. A new family of Boucher-Neuhauser syndrome: Coexistence of Holmes type cerebellar atrophy, hypogonadotropic hypogonadism and retinochoroidal degeneration: Case reports and review of literature. Endocr J1995;42:367–376.
215.
De MicheleGFillaAStrianoS. [Cerebellar ataxia and hypogonadism. Description of 4 cases]. Riv Neurol1987;57: 328–332.
216.
JohkuraKYamaguchiSMatsumotoMNagatomoHHasegawaOKuroiwaY. [Cerebellar ataxia with hypogonadotropic hypogonadism and mental disturbance]. No To Shinkei1994;46:493–496.
217.
ShilohY. Ataxia-telangiectasia: Closer to unraveling the mystery. Eur J Hum Genet1995;3:116–138.
218.
CarbonariMCherchiMPaganelliR. Relative increase of T cells expressing the gamma/delta rather than the alpha/beta receptor in ataxia-telangiectasia. N Engl J Med1990;322: 73–76.
219.
OxeliusVABerkelAIHansonLA. IgG2 deficiency in ataxia-telangiectasia. N Engl J Med1982;306:515–517.
220.
ToyoshimaMHaraTZhangH. Ataxia-telangiectasia without immunodeficiency: Novel point mutations within and adjacent to the phosphatidylinositol 3-kinase-like domain. Am J Med Genet1998; 75:141–144.
221.
WaldmanTA. Immunological abnormalities in ataxia-telangiectasia. In: BridgesBAHarndenDG, eds. Ataxia-Telangiectasia: A Cellular and Molecular Link Between Cancer, Neuropathology and Immune Deficiency. Chichester: John Wiley; 1982:37–51.
222.
ItoMNakagawaAHirabayashiNAsaiJ. Bronchiolitis obliterans in ataxia-telangiectasia. Virchows Arch1997;430:131–137.
223.
KovacsKGianniniCScheithauerBWStefaneanuLLloydRVHorvathE. Pituitary changes in ataxia-telangiectasia syndrome: An immunocytochemical, in situ hybridization, and DNA cytometric study of three cases. Endocr Pathol1997;8:195–203.
224.
FrappartPOMcKinnonPJ. Ataxia-telangiectasia and related diseases. Neuromolecular Med2006;8:495–511.
225.
GuleriaAChandnaS. ATM kinase: Much more than a DNA damage responsive protein. DNA Repair (Amst)2016;39:1–20.
226.
HardingAE. Clinical features and classification of inherited ataxias. Adv Neurol1993;61:1–14.
227.
HardingAE. Friedreich's ataxia: A clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain1981;104:589–620.
228.
LynchDRFarmerJMBalcerLJWilsonRB. Friedreich ataxia: Effects of genetic understanding on clinical evaluation and therapy. Arch Neurol2002;59:743–747.
229.
CabreroMayo DCristobalHernandez JDuqueCantarero S. [Distribution of dominant hereditary ataxias and Friedreich's ataxia in the Spanish population]. Med Clin (Barc)2000;115:121–125.
230.
CarvajalJJPookMAdos SantosM. The Friedreich's ataxia gene encodes a novel phosphatidylinositol-4-phosphate 5-kinase. Nat Genet1996;14:157–162.
231.
LiKSinghACrooksDR. Expression of human frataxin is regulated by transcription factors SRF and TFAP2. PLoS One2010;5:e12286.
232.
SaccaFPuorroGAntenoraA. A combined nucleic acid and protein analysis in Friedreich ataxia: Implications for diagnosis, pathogenesis and clinical trial design. PLoS One2011;6:e17627.
233.
PandolfoMPastoreA. The pathogenesis of Friedreich ataxia and the structure and function of frataxin. J Neurol2009;256(suppl 1):9–17.
234.
ChamberlainSShawJRowlandA. Mapping of mutation causing Friedreich's ataxia to human chromosome 9. Nature1988; 334:248–250.
235.
BartoloCMendellJRPriorTW. Identification of a missense mutation in a Friedreich's ataxia patient: Implications for diagnosis and carrier studies. Am J Med Genet1998;79:396–399.
236.
CampuzanoVMonterminiLMoltoMD. Friedreich's ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science1996;271:1423–1527.
237.
PandolfoM. Friedreich ataxia: Detection of GAA repeat expansions and frataxin point mutations. Methods Mol Med2006;126: 197–216.
238.
MonterminiLRichterAMorganK. Phenotypic variability in Friedreich ataxia: Role of the associated GAA triplet repeat expansion. Ann Neurol1997;41:675–682.
239.
XiaHCaoYDaiX. Novel frataxin isoforms may contribute to the pathological mechanism of Friedreich ataxia. PLoS One2012;7:e47847.
240.
Holmes GA form of familial degeneration of the cerebellum. Brain1907;30:466–489.
241.
SeminaraSBAciernoJSJrAbdulwahidNACrowleyWFJrMargolinDH. Hypogonadotropic hypogonadism and cerebellar ataxia: Detailed phenotypic characterization of a large, extended kindred. J Clin Endocrinol Metab2002;87:1607–1612.
242.
QuintonRBarnettPCoskeranPBoulouxPM. Gordon Holmes spinocerebellar ataxia: A gonadotrophin deficiency syndrome resistant to treatment with pulsatile gonadotrophin-releasing hormone. Clin Endocrinol (Oxf)1999;51:525–529.
243.
BoucherBJGibberdFB. Familial ataxia, hypogonadism and retinal degeneration. Acta Neurol Scand1969;45:507–510.
244.
OgawaSAikawaSKatoT. Prominent expression of spinocerebellar ataxia type-1 (SCA1) gene encoding ataxin-1 in LH-producing cells, LbetaT2. J Reprod Dev2004;50:557–563.
245.
RizziRCarelliVMonariL. Cerebellar ataxia, hypogonadism and chorioretinopathy: Molecular analysis of an Italian family. Ital J Neurol Sci1998;19:41–44.
246.
UmeharaTYaguchiHSuzukiMIsozakiEMochioS. Are hypersegmented neutrophils a characteristic of Boucher-Neuhauser syndrome?J Neurol Sci2010;295:128–130.
247.
NistalMPaniaguaRGonzález-PeramatoReyes-MúgicaM. Perspectives in pediatric pathology, chapter 21. Testicular pathology in heritable metabolic disease. Pediatr Dev Pathol. In press.
248.
TimmonsMTsokosMAsabMA. Peripheral and central hypomyelination with hypogonadotropic hypogonadism and hypodontia. Neurology2006;67:2066–2069.
249.
WolffAKochMJBenzingerS. Rare dental peculiarities associated with the hypomyelinating leukoencephalopathy 4H syndrome/ADDH. Pediatr Dent2010;32:386–392.
250.
PoticABraisBChoquetKSchiffmannRBernardG. 4H syndrome with late-onset growth hormone deficiency caused by POLR3A mutations. Arch Neurol2012;69:920–923.
251.
TeraoYSaitsuHSegawaM. Diffuse central hypomyelination presenting as 4H syndrome caused by compound heterozygous mutations in POLR3A encoding the catalytic subunit of polymerase III. J Neurol Sci2012;320:102–105.
252.
BernardGChoueryEPutortiML. Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy. Am J Hum Genet2011;89:415–423.
253.
TetreaultMChoquetKOrcesiS. Recessive mutations in POLR3B, encoding the second largest subunit of Pol III, cause a rare hypomyelinatingleukodystrophy. Am J Hum Genet2011;89:652–655.
254.
AlsemariA. Hypogonadism and neurological diseases. Neurol Sci2013;34:629–638.
255.
JenkinsonEMKingstonHUrquhartJ. Newly recognized recessive syndrome characterized by dysmorphic features, hypogonadotropic hypogonadism, severe microcephaly, and sensorineural hearing loss maps to 3p21.3. Am J Med Genet A2011; 155A:2910–2915.
256.
CarpenterG. Two sisters showing malformations of the skull and other congenital abnormalities. Rep Soc Study Dis Child Lond1901;1:110–118.
257.
BlankensteinRBrookAHSmithRNPatrickDRussellJM. Oral findings in Carpenter syndrome. Int J Paediatr Dent2001;11:352–360.
JenkinsDBaynamGDe CatteL. Carpenter syndrome: Extended RAB23 mutation spectrum and analysis of nonsensemediated mRNA decay. Hum Mutat2011;32:E2069–E2078.
260.
JenkinsDSeelowDJeheeFS. RAB23 mutations in Carpenter syndrome imply an unexpected role for hedgehog signaling in cranial-suture development and obesity. Am J Hum Genet2007;80:1162–1170.
261.
VerloesATempleIKBonnetSBottaniA. Coloboma, mental retardation, hypogonadism, and obesity: Critical review of the so-called Biemond syndrome type 2, updated nosology, and delineation of three “new” syndromes. Am J Med Genet1997;69: 370–379.
262.
AdamsNAAwadeinATomaHS. The retinal ciliopathies. Ophthalmic Genet2007;28:113–125.
263.
FraserGF. Our genetic “load”. A review of some aspects of genetic variation. Ann Hum Genet1962;25:387–415.
264.
ComstockJMPutnamAROpitzJMPysherTJSzakacsJ. Prenatal death in Fraser syndrome. Fetal Pediatr Pathol2005;24: 223–238.
265.
Martinez-FriasMLBermejoEOteroSanchez TUriosteMMorenaVCruzE. Sclerocornea, hypertelorism, syndactyly, and ambiguous genitalia. Am J Med Genet1994;49:195–197.
266.
BarisicIOdakLLoaneM. Fraser syndrome: Epidemiological study in a European population. Am J Med Genet A2013; 161A:1012–1018.
267.
BierichJRChristieMHeinrichJJMartinezAS. New observations on midline defects: Coincidence of anophthalmos, microphthalmos and cryptophthalmos with hypothalamic disorders. Eur J Pediatr1991;150:246–249.
268.
van HaelstMMMaiburgMBaujatG. Molecular study of 33 families with Fraser syndrome new data and mutation review. Am J Med Genet A2008;146A:2252–2257.
269.
SchanzeDKayseriliHSatkinBNAltunogluUZenkerM. Fraser syndrome due to mutations in GRIP1—clinical phenotype in two families and expansion of the mutation spectrum. Am J Med Genet A2014;164a:837–840.
270.
VogelMJvan ZonPBruetonL. Mutations in GRIP1 cause Fraser syndrome. J Med Genet2012;49:303–306.
271.
PavlakisEChiotakiRChalepakisG. The role of Fras1/Frem proteins in the structure and function of basement membrane. Int J Biochem Cell Biol2011;43:487–495.